Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 9,960.00
-90.00 (-0.90%)
At close: Aug 3, 2026
Whan In Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 184,100 | 172,823 | 180,304 | 229,617 | 268,700 | 271,754 | |
Market Cap Growth | -1.00% | -4.15% | -21.48% | -14.54% | -1.12% | 6.59% |
Enterprise Value | 121,062 | 113,895 | 129,280 | 155,357 | 180,073 | 139,039 |
Last Close Price | 9960.00 | 11320.00 | 11504.57 | 14288.98 | 16384.71 | 16287.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.41 | 12.71 | 7.71 | 7.71 | 11.23 | 10.19 |
Forward PE | 8.41 | 12.26 | 8.95 | 10.19 | 11.78 | 10.83 |
PS Ratio | 0.69 | 0.68 | 0.70 | 1.00 | 1.35 | 1.53 |
PB Ratio | 0.43 | 0.41 | 0.48 | 0.64 | 0.81 | 0.86 |
P/TBV Ratio | 0.44 | 0.42 | 0.49 | 0.65 | 0.81 | 0.87 |
P/FCF Ratio | 47.05 | 27.90 | - | - | - | 8.79 |
P/OCF Ratio | 30.29 | 19.11 | 8.71 | 9.90 | 15.95 | 7.69 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.45 | 0.45 | 0.50 | 0.67 | 0.91 | 0.78 |
EV/EBITDA Ratio | 4.53 | 4.98 | 4.31 | 4.22 | 5.20 | 3.92 |
EV/EBIT Ratio | 7.17 | 8.75 | 6.01 | 5.15 | 6.04 | 4.45 |
EV/FCF Ratio | 30.94 | 18.39 | - | - | - | 4.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.02 | 0.03 | 0.01 | 0.02 | 0.01 | 0.05 |
Debt / FCF Ratio | 0.15 | 0.11 | - | - | - | 0.06 |
Net Debt / Equity Ratio | -0.15 | -0.15 | -0.14 | -0.22 | -0.26 | -0.45 |
Net Debt / EBITDA Ratio | -2.34 | -2.75 | -1.74 | -2.11 | -2.51 | -4.07 |
Net Debt / FCF Ratio | -16.11 | -10.18 | 7.83 | 10.61 | 5.18 | -4.66 |
Asset Turnover | 0.58 | 0.56 | 0.63 | 0.60 | 0.55 | 0.52 |
Inventory Turnover | 2.01 | 2.00 | 2.62 | 2.89 | 2.87 | 2.58 |
Quick Ratio | 2.37 | 2.30 | 3.03 | 3.93 | 5.03 | 6.77 |
Current Ratio | 4.10 | 4.04 | 4.75 | 5.30 | 6.22 | 7.85 |
Return on Equity (ROE) | 3.98% | 3.41% | 6.37% | 8.60% | 7.29% | 8.62% |
Return on Assets (ROA) | 2.35% | 1.80% | 3.25% | 4.89% | 5.16% | 5.73% |
Return on Invested Capital (ROIC) | 3.95% | 3.48% | 6.17% | 10.08% | 11.31% | 13.77% |
Return on Capital Employed (ROCE) | 4.00% | 3.10% | 5.60% | 8.40% | 8.80% | 9.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.66% | 7.87% | 12.97% | 12.97% | 8.90% | 9.81% |
FCF Yield | 2.13% | 3.58% | -3.70% | -3.19% | -6.25% | 11.38% |
Dividend Yield | 2.98% | 2.65% | 2.61% | 2.10% | 1.83% | 1.84% |
Payout Ratio | 28.73% | 33.69% | 19.59% | 15.38% | 19.15% | 17.18% |
Buyback Yield / Dilution | -9.13% | -3.86% | - | - | - | - |
Total Shareholder Return | -6.14% | -1.21% | 2.61% | 2.10% | 1.83% | 1.84% |